Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Marcoen F. Scholten"'
Autor:
Anna van Veelen, Tom E. Verstraelen, Yvemarie B. O. Somsen, Joëlle Elias, Ivo M. van Dongen, Peter Paul H. M. Delnoy, Marcoen F. Scholten, Lucas V. A. Boersma, Alexander H. Maass, Sipke Strikwerda, Mehran Firouzi, Cornelis P. Allaart, Kevin Vernooy, Robert W. Grauss, Raymond Tukkie, Paul Knaapen, Aeilko H. Zwinderman, Marcel G. W. Dijkgraaf, Bimmer E. P. M. Claessen, Marit van Barreveld, Arthur A. M. Wilde, José P. S. Henriques
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 8 (2024)
Background Chronic total coronary occlusions (CTO) substantially increase the risk for sudden cardiac death. Among patients with chronic ischemic heart disease at risk for sudden cardiac death, an implantable cardioverter defibrillator (ICD) is the f
Externí odkaz:
https://doaj.org/article/16c704d93d8647e7ac20bbcc9562b5d0
Autor:
Sanne A. Groeneveld, Lisa M. Verheul, Martijn H. van der Ree, Bart A. Mulder, Marcoen F. Scholten, Marco Alings, Pepijn van der Voort, Marianne Bootsma, Reinder Evertz, Jippe C. Balt, Sing-Chien Yap, Pieter.A.F.M. Doevendans, Pieter G. Postema, Arthur A.M. Wilde, Paul G.A. Volders, Rutger J. Hassink
Publikováno v:
JACC: Clinical Electrophysiology. 9:345-355
Autor:
Laurent Pison, Carl Timmermans, Marleen M. D. Molenaar, Tim Hesselink, Karin Kraaier, Jurren M. van Opstal, Randy Manusama, Marjolein Brusse-Keizer, Jan G. Grandjean, Bernard ten Haken, Rachel M.A. ter Bekke, Marcoen F. Scholten
Publikováno v:
Pacing and Clinical Electrophysiology, 43(10), 1173-1179. Wiley
Pacing and clinical electrophysiology, 43(10), 1173-1179. Wiley-Blackwell
Pacing and clinical electrophysiology, 43(10), 1173-1179. Wiley-Blackwell
Background: In the 123-study, we prospectively assessed, in a randomized fashion, the minimal cryoballoon application time necessary to achieve pulmonary vein (PV) isolation (PVI) in patients with paroxysmal atrial fibrillation (AF) with the aim to r
Autor:
Michiel Hulleman, Anton E. Tuinenburg, Peter-Paul Delnoy, Frank A.L.E. Bracke, Dominic A.M.J. Theuns, René Abels, Sipke Strikwerda, Gerard L Bartels, Alida E Borger van der Burg, Raymond Tukkie, Marit van Barreveld, Alexander H. Maass, Marc A. Brouwer, Mehran Firouzi, G.P. Kimman, Nick R. Bijsterveld, Pepijn H. van der Voort, Mathias Meine, Tim Friede, Christian Sticherling, Marcoen F. Scholten, Markus Zabel, Reinoud E. Knops, Jan Elders, Erik Buskens, Rik Willems, Pascal H F M van Dessel, Markus Harden, Jos Widdershoven, Richard Derksen, Mattheus W Vet, Robert W Grauss, Lieselot van Erven, Tom E Verstraelen, Han A M Spierenburg, Marcel G. W. Dijkgraaf, Aeilko H. Zwinderman, Cornelis P Allaart, Lucas V.A. Boersma, Muchtiar Khan, Arthur A.M. Wilde, Kevin Vernooy, Marco W.F. van Gent
Publikováno v:
Europace, 23(6):euab012, 887-897. Oxford University Press
Europace, 23, 887-897
Europace, 23, 6, pp. 887-897
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 23(6), 887-897. Oxford University Press
EP Europace, 23(6), 887-897. OXFORD UNIV PRESS
Europace, 23(6), 887-897. OXFORD UNIV PRESS
Europace
Europace, 23(6), 887-897. Oxford University Press
Verstraelen, T E, van Barreveld, M, van Dessel, P H F M, Boersma, L V A, Delnoy, P-P P H M, Tuinenburg, A E, Theuns, D A M J, van der Voort, P H, Kimman, G P, Buskens, E, Hulleman, M, Allaart, C P, Strikwerda, S, Scholten, M F, Meine, M, Abels, R, Maass, A H, Firouzi, M, Widdershoven, J W M G, Elders, J, van Gent, M W F, Khan, M, Vernooy, K, Grauss, R W, Tukkie, R, van Erven, L, Spierenburg, H A M, Brouwer, M A, Bartels, G L, Bijsterveld, N R, Borger van der Burg, A E, Vet, M W, Derksen, R, Knops, R E, Bracke, F A L E, Harden, M, Sticherling, C, Willems, R, Friede, T, Zabel, M, Dijkgraaf, M G W, Zwinderman, A H & Wilde, A A M 2021, ' Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death ', Europace, vol. 23, no. 6, pp. 887-897 . https://doi.org/10.1093/europace/euab012
Europace : European pacing, arrhythmias, and cardiac electrophysiology, 23(6), 887-897. Oxford University Press
EP Europace, 23(6), 887-897. Oxford University Press
Europace, 23, 887-897
Europace, 23, 6, pp. 887-897
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 23(6), 887-897. Oxford University Press
EP Europace, 23(6), 887-897. OXFORD UNIV PRESS
Europace, 23(6), 887-897. OXFORD UNIV PRESS
Europace
Europace, 23(6), 887-897. Oxford University Press
Verstraelen, T E, van Barreveld, M, van Dessel, P H F M, Boersma, L V A, Delnoy, P-P P H M, Tuinenburg, A E, Theuns, D A M J, van der Voort, P H, Kimman, G P, Buskens, E, Hulleman, M, Allaart, C P, Strikwerda, S, Scholten, M F, Meine, M, Abels, R, Maass, A H, Firouzi, M, Widdershoven, J W M G, Elders, J, van Gent, M W F, Khan, M, Vernooy, K, Grauss, R W, Tukkie, R, van Erven, L, Spierenburg, H A M, Brouwer, M A, Bartels, G L, Bijsterveld, N R, Borger van der Burg, A E, Vet, M W, Derksen, R, Knops, R E, Bracke, F A L E, Harden, M, Sticherling, C, Willems, R, Friede, T, Zabel, M, Dijkgraaf, M G W, Zwinderman, A H & Wilde, A A M 2021, ' Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death ', Europace, vol. 23, no. 6, pp. 887-897 . https://doi.org/10.1093/europace/euab012
Europace : European pacing, arrhythmias, and cardiac electrophysiology, 23(6), 887-897. Oxford University Press
EP Europace, 23(6), 887-897. Oxford University Press
Aims This study was performed to develop and externally validate prediction models for appropriate implantable cardioverter-defibrillator (ICD) shock and mortality to identify subgroups with insufficient benefit from ICD implantation. Methods and res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73d4fff9d6966b3bba98be7f6d7848df
https://research.rug.nl/en/publications/717836bf-8f1d-408e-8cf9-bb5c8e133753
https://research.rug.nl/en/publications/717836bf-8f1d-408e-8cf9-bb5c8e133753
Autor:
Petr Neuzil, A Brisben, Jürgen Kuschyk, Pd. Lambiase, Damj Theuns, Marcoen F. Scholten, Craig S. Barr, Reinoud E. Knops, Lars Eckardt, Margaret Hood, Francis Murgatroyd, Nathan Carter, L. V. A. Boersma
Publikováno v:
EP Europace. 23
Funding Acknowledgements Type of funding sources: Private company. Main funding source(s): Boston Scientific OnBehalf EFFORTLESS Registry Introduction Patients (pts) implanted with transvenous (TV) implantable cardioverter-defibrillator (ICD) experie
Autor:
Edgar Zitron, Susanne S. Pedersen, Sébastien Prevot, Geert Jan Kimman, Henneke Versteeg, Johan Denollet, Marcoen F. Scholten, Philippe Mabo, Thomas Rauwolf, Mathias Meine, Ivy Timmermans, Jos Widdershoven
Publikováno v:
Europace, 21(9), 1360-1368. OXFORD UNIV PRESS
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 21(9), 1360. Oxford University Press
Europace
Versteeg, H, Timmermans, I, Widdershoven, J, Kimman, G-J, Prevot, S, Rauwolf, T, Scholten, M F, Zitron, E, Mabo, P, Denollet, J, Pedersen, S S & Meine, M 2019, ' Effect of remote monitoring on patient-reported outcomes in European heart failure patients with an implantable cardioverter-defibrillator : primary results of the REMOTE-CIED randomized trial ', Europace, vol. 21, no. 9, pp. 1360-1368 . https://doi.org/10.1093/europace/euz140
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 21(9), 1360. Oxford University Press
Europace
Versteeg, H, Timmermans, I, Widdershoven, J, Kimman, G-J, Prevot, S, Rauwolf, T, Scholten, M F, Zitron, E, Mabo, P, Denollet, J, Pedersen, S S & Meine, M 2019, ' Effect of remote monitoring on patient-reported outcomes in European heart failure patients with an implantable cardioverter-defibrillator : primary results of the REMOTE-CIED randomized trial ', Europace, vol. 21, no. 9, pp. 1360-1368 . https://doi.org/10.1093/europace/euz140
AimsThe European REMOTE-CIED study is the first randomized trial primarily designed to evaluate the effect of remote patient monitoring (RPM) on patient-reported outcomes in the first 2 years after implantation of an implantable cardioverter-defibril
Autor:
D.E. Bouman, Y. J. Stevenhagen, B. ten Haken, Tim Hesselink, P. F. H. M. van Dessel, Marleen M. D. Molenaar, Marcoen F. Scholten, Marjolein Brusse-Keizer, Karin Kraaier, Jan G. Grandjean, J. M. van Opstal
Publikováno v:
Netherlands Heart Journal
Netherlands heart journal, 28(12), 662-669. Bohn Stafleu Van Loghum
Netherlands heart journal, 28(12), 662-669. Bohn Stafleu Van Loghum
Background Low oesophageal temperatures (OTs) during cryoballoon pulmonary vein isolation (PVI) have been associated with complications. This study assessed the incidence of low OT in clinical practice during cryoballoon PVI and verified possible pre
Autor:
Tim Hesselink, Georgios J. Vlachojannis, Antoinette Milané-Santman, Johannes G. Krabbe, Marcoen F. Scholten, Evelien W.M. Kemna, Mark W.M. Schellings, Florian Falter
Publikováno v:
The Journal of Applied Laboratory Medicine. 4:468-470
To the Editor: Activated clotting time (ACT) is used to monitor unfractionated heparin anticoagulation during invasive procedures such as percutaneous coronary or electrophysiology interventions. There are several point-of-care (POC) methods availabl
Publikováno v:
Netherlands Heart Journal
Autor:
Margaret Hood, Elizabeth Duffy, Dominic A.M.J. Theuns, Paul W. Jones, Juergen Kuschyk, Kenneth M. Stein, Marcoen F. Scholten, Pier D. Lambiase, Petr Neuzil, Lars Eckardt, Lucas V.A. Boersma, Craig S. Barr, Reinoud E. Knops, Michael Husby
Publikováno v:
Journal of the American College of Cardiology. 70:830-841
Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to defibrillate ventricular arrhythmias, avoiding drawbacks of transvenous leads. The global EFFORTLESS S-ICD (Evaluation oF FactORs ImpacTing CLinical Outcome a